Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Mar 1;143(3):601-14.
doi: 10.1084/jem.143.3.601.

Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells

Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells

J W Schrader et al. J Exp Med. .

Abstract

Cytotoxic T lymphocytes were generated in vitro against H-2 compatible or syngeneic tumor cells. In vitro cytotoxic activity was inhibited by specific anti-H2 sera, suggesting that H-2 antigens are involved in cell lysis. Two observations directly demonstrated the participation of the H-2 antigens on the tumor cells in their lysis by H-2-compatible T cells. First, coating of the H-2 antigens on the target tumor cell reduced the number of cells lysed on subsequent exposure to cytotoxic T cells. Second, when cytotoxic T cells were activated against an H-2 compatible tumor and assayed against an H-2-incompatible tumor, anti-H-2 serum that could bind to the target cell, but not to the cytotoxic lymphocyte, inhibited lysis. H-2 antigens were also shown to be present on the cytotoxic lymphocytes. Specific antisera reacting with these H-2 antigens, but not those of the target cell, failed to inhibit lysis when small numbers of effector cells were assayed against H-2-incompatible target cells or when effector cells of F1-hybrid origin and bearing two H-2 haplotypes were assayed against a tumor cell of one of the parental strains. These findings suggest that it is the H-2 antigens on the tumor cell and not those on the cytotoxic lymphocytes that are important in cell-mediated lysis of H-2-compatible tumor cells.

PubMed Disclaimer

References

    1. Eur J Immunol. 1975 Aug;5(8):560-4 - PubMed
    1. Eur J Immunol. 1975 Apr;5(4):245-51 - PubMed
    1. Scand J Immunol. 1975;4(1):53-62 - PubMed
    1. Proc Natl Acad Sci U S A. 1976 Jan;73(1):118-22 - PubMed
    1. J Immunol. 1974 Apr;112(4):1548-52 - PubMed

Publication types